---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-001170"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2024-01-05T23:59:59+00:00"
generated_at: "2026-06-07T03:29:36.461188+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SEC declares effective registration statement for Semper Paratus–Tevogen Bio merger; $1.2B equity value

## Summary
- SEC declared effective the Form S-4 for the business combination between Semper Paratus (LGST) and Tevogen Bio.
- Pro forma equity value of combined company attributable to Tevogen stockholders expected to be $1.2 billion.
- Special meeting of Semper Paratus stockholders to approve the transaction; closing expected shortly after subject to approvals.
- Post-closing combined company will be renamed Tevogen Bio Holdings Inc.

## SEC filing metadata
- accession: 0001493152-24-001170
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2024-01-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315224001170/0001493152-24-001170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315224001170/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-001170
- JSON: https://secwatch.observer/filing/0001493152-24-001170.json
- Plain text: https://secwatch.observer/filing/0001493152-24-001170.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.